Most ccRCC have somatic mutations of both alleles of pVHL (von Hippel-Lindau), a component of an E3 ubiquitin ligase complex, which targets the hypoxia-inducible factors (HIF), HIF-1α and HIF-2α, for degradation [5]. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.